Dr. Weissman on Keytruda

Sep 10, 2014


New York Oncology Hematology’s Dr. Charles Weissman, an expert on melanoma, speaks with Newschannel 13 health reporter Benita Zahn about the groundbreaking FDA approval of anti-cancer drug Keytruda.

Jack Lewis, a patient of Dr. Weissman’s, who is currently participating in a clinical trial through New York Oncology Hematology for another melanoma treatment, shares his story and why he believes the clinical trial treatment is helping him live a longer life.

With the largest, most comprehensive clinical trial program in the region, New York Oncology Hematology and our patients have played a pivotal role in FDA approval of 38 anti-cancer drugs over the past 20 years.